Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

35 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Taxanes in adjuvant breast cancer setting: which standard in Europe?
Campone M, Fumoleau P, Bourbouloux E, Kerbrat P, Roché H. Campone M, et al. Among authors: bourbouloux e. Crit Rev Oncol Hematol. 2005 Sep;55(3):167-75. doi: 10.1016/j.critrevonc.2005.04.003. Crit Rev Oncol Hematol. 2005. PMID: 16039867 Review.
[Cardiac dysfunction induced by trastuzumab].
Campone M, Bourbouloux E, Fumoleau P. Campone M, et al. Among authors: bourbouloux e. Bull Cancer. 2004 Nov;91 Suppl 3:166-73. Bull Cancer. 2004. PMID: 15899624 Review. French.
Brown fat in breast cancer patients: analysis of serial (18)F-FDG PET/CT scans.
Rousseau C, Bourbouloux E, Campion L, Fleury N, Bridji B, Chatal JF, Resche I, Campone M. Rousseau C, et al. Among authors: bourbouloux e. Eur J Nucl Med Mol Imaging. 2006 Jul;33(7):785-91. doi: 10.1007/s00259-006-0066-x. Epub 2006 Apr 5. Eur J Nucl Med Mol Imaging. 2006. PMID: 16596378 Clinical Trial.
Vinflunine: a new active drug for second-line treatment of advanced breast cancer. Results of a phase II and pharmacokinetic study in patients progressing after first-line anthracycline/taxane-based chemotherapy.
Campone M, Cortes-Funes H, Vorobiof D, Martin M, Slabber CF, Ciruelos E, Bourbouloux E, Mendiola C, Delgado FM, Colin C, Aslanis V, Fumoleau P. Campone M, et al. Among authors: bourbouloux e. Br J Cancer. 2006 Nov 6;95(9):1161-6. doi: 10.1038/sj.bjc.6603347. Epub 2006 Oct 10. Br J Cancer. 2006. PMID: 17031408 Free PMC article. Clinical Trial.
Phase I dose-escalation study of a novel antitumor agent, SR271425, administered intravenously in split doses (d1-d2-d3) in patients with refractory solid tumors.
Campone M, Isambert N, Bourbouloux E, Maury S, Monin-Baroille P, Berille J, Fumoleau P. Campone M, et al. Among authors: bourbouloux e. Cancer Chemother Pharmacol. 2007 Apr;59(5):689-95. doi: 10.1007/s00280-006-0349-8. Epub 2006 Oct 10. Cancer Chemother Pharmacol. 2007. PMID: 17031647 Clinical Trial.
Monitoring of early response to neoadjuvant chemotherapy in stage II and III breast cancer by [18F]fluorodeoxyglucose positron emission tomography.
Rousseau C, Devillers A, Sagan C, Ferrer L, Bridji B, Campion L, Ricaud M, Bourbouloux E, Doutriaux I, Clouet M, Berton-Rigaud D, Bouriel C, Delecroix V, Garin E, Rouquette S, Resche I, Kerbrat P, Chatal JF, Campone M. Rousseau C, et al. Among authors: bourbouloux e. J Clin Oncol. 2006 Dec 1;24(34):5366-72. doi: 10.1200/JCO.2006.05.7406. Epub 2006 Nov 6. J Clin Oncol. 2006. PMID: 17088570 Clinical Trial.
Prognostic impact of syndecan-1 expression in invasive ductal breast carcinomas.
Loussouarn D, Campion L, Sagan C, Frenel JS, Dravet F, Classe JM, Pioud-Martigny R, Berton-Rigaud D, Bourbouloux E, Mosnier JF, Bataille FR, Campone M. Loussouarn D, et al. Among authors: bourbouloux e. Br J Cancer. 2008 Jun 17;98(12):1993-8. doi: 10.1038/sj.bjc.6604400. Epub 2008 Jun 10. Br J Cancer. 2008. PMID: 18542065 Free PMC article.
Lapatinib in metastatic breast cancer.
Frenel JS, Bourbouloux E, Berton-Rigaud D, Sadot-Lebouvier S, Zanetti A, Campone M. Frenel JS, et al. Among authors: bourbouloux e. Womens Health (Lond). 2009 Nov;5(6):603-12. doi: 10.2217/whe.09.54. Womens Health (Lond). 2009. PMID: 19863462 Review.
35 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page